Business Wire

EGYPTIAN-TOURISM

16.3.2023 14:11:45 CET | Business Wire | Press release

Share
Egypt Beats Classic UK Holiday Destinations in Both Attractiveness and Price

The most popular foreign destinations for British holidaymakers are Italy and Spain. However, what many travellers do not know: For the price they spend on a holiday in these countries, they could experience more luxury and adventure in Egypt.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230216005515/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Winter in Egypt (Photo: Business Wire)

What Brits pay for their holidays abroad

Brits love to travel, but how much do they actually spend on their holidays? According to National Institute of statistics (Ine), the British invested an average of £1,0001 per person on a trip in 2021. However, a one-week stay including meals in a three-star hotel in Italy, for example, can cost up to £1,300 even in the low season. And that doesn't even include sightseeing, theatre tickets or museum visits.

In Egypt, two people can spend seven nights in a five-star hotel for less than the average price of a holiday in an Italian coastal region - all-inclusive, of course. The return flight from a major UK city is also included here. This leaves a lot of the budget for excursions and activities.

From paradisiacal beaches to the impressive expanse of the desert

Egypt has a lot to offer for all travelers - whether they are sun worshippers looking to relax on the beautiful coasts or culture vultures in search of ancient sites steeped in history. "Over the past two years, when we had restrictions on travel due to the pandemic, Egypt has been improving its travel infrastructure and working to expand what it has to offer visitors," says Amr El-Kady, managing director of the Egyptian Tourism Authority. "Even tourists who have visited Egypt before will now be able to discover many new options for things to do and interesting things to see. There are numerous, fantastic new accommodations available as domiciles."

For beach and sea lovers, the entire Egyptian coast is an ideal destination. You'll find plenty of white sandy beaches and warm, crystal-clear waters on both the Mediterranean and the Red Sea. From the beach resorts in Sharm El Sheikh on the Sinai Peninsula and Hurghada on Egypt's east coast, you can enjoy breathtaking views over the Red Sea. From here, you can also explore the mystical mountain regions inland. The Red Sea is also home to some of the most beautiful coral reefs in the world and can be explored by both amateur and professional divers. The Mediterranean coast from Alexandria to Marsa Matruh also beckons with turquoise waters and seemingly endless sandy beaches that invite you to swim, dive and sunbathe.

Those who prefer to discover and enjoy the incomparable beauty of the desert will not be disappointed either and can expect an experience like from 1001 Nights. In the Sinai desert, hiking and camel safaris offer an unforgettable experience for outdoor enthusiasts.

Tradition and history in the cities of the pharaohs

Among the most impressive historical sites is the magnificent city of Luxor with its spectacular sights such as the Valley of the Kings, the Temple of Karnak, and the legendary Luxor Temple. For a special experience, take a hot air balloon ride for a majestic view of the city on the Nile from above.

Fans of city trips should have Cairo on their agenda: In the Egyptian capital, millennia-old relics of antiquity meet the modern culture of the Middle East. The Great Sphinx and the Pyramids of Giza - the only remaining wonder of the ancient world - are unique buildings and an impressive testimony to ancient architecture. The history of the country is also presented in detail in the Egyptian Museum: It houses over 120,000 artefacts, including the treasures from Tutankhamun's tomb.

The Khan El Khalili bazaar is one of the oldest and most famous markets in the Middle East: here, holidaymakers can not only find authentic souvenirs but also enjoy the specialties of the local cuisine and get to know contemporary Egyptian culture.

Anyone looking for a multifaceted, historical and affordable travel destination should try Egypt to see for themselves the rich variety of this country with their own eyes and senses.

1 Ine (2022) Gasto de los turistas internacionales segun pais de residencia. Taken from: https://www.ine.es/jaxiT3/Datos.htm?t=10838#!tabs-tabla

– ENDE –

For further information:
https://www.experienceegypt.eg/

About the Egyptian Tourism Board

The Egyptian Tourism Board, established in 1981, is a regulatory body affiliated with the Ministry of Tourism. Its mission is to stimulate international tourism by promoting Egypt's rich history and civilization and highlighting the country's many tourist attractions. It also aims to promote domestic tourism, raise awareness of tourism throughout the country and strengthen the link between Egyptians and their heritage.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230216005515/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye